Pacific Biosciences
PACB
#7234
Rank
ยฃ0.30 B
Marketcap
ยฃ1.01
Share price
-1.50%
Change (1 day)
-64.69%
Change (1 year)

Operating Margin for Pacific Biosciences (PACB)

Operating Margin as of March 2025 (TTM): -192.27%

According to Pacific Biosciences 's latest financial reports and stock price the company's current Operating Margin is -192.27%. At the end of 2024 the company had an Operating Margin of -192.27%.

Operating Margin history for Pacific Biosciences from 2010 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-192.27%26.9%
2023-151.51%-35.11%
2022-233.48%16.15%
2021-201.01%-634.48%
202037.61%-141.93%
2019-89.69%-29.58%
2018-127.36%33.35%
2017-95.51%21.78%
2016-78.42%152.91%
2015-31.01%-70.33%
2014-104.52%-61.66%
2013-272.58%-24.81%
2012-362.51%12.52%
2011-322.18%-96.15%
2010-8,377.18%-87.16%
2009-65,237.04%1211.76%
2008-4,973.25%359.88%
2007-1,081.41%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-26.96%-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-97.64%-49.22%๐Ÿ‡บ๐Ÿ‡ธ USA
19.68%-110.24%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
16.41%-108.53%๐Ÿ‡บ๐Ÿ‡ธ USA
14.13%-107.35%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.